PL1855677T3 - 3,11B-Cis-dihydrotetrabenazyny do leczenia schizofrenii i innych psychoz - Google Patents
3,11B-Cis-dihydrotetrabenazyny do leczenia schizofrenii i innych psychozInfo
- Publication number
- PL1855677T3 PL1855677T3 PL06765238T PL06765238T PL1855677T3 PL 1855677 T3 PL1855677 T3 PL 1855677T3 PL 06765238 T PL06765238 T PL 06765238T PL 06765238 T PL06765238 T PL 06765238T PL 1855677 T3 PL1855677 T3 PL 1855677T3
- Authority
- PL
- Poland
- Prior art keywords
- psychoses
- schizophrenia
- cis
- treatment
- dihydrotetrabanezine
- Prior art date
Links
- 208000028017 Psychotic disease Diseases 0.000 title abstract 2
- 201000000980 schizophrenia Diseases 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0516167.4A GB0516167D0 (en) | 2005-08-06 | 2005-08-06 | Pharmaceutical compounds |
| GB0516790A GB0516790D0 (en) | 2005-08-16 | 2005-08-16 | Pharmaceutical compounds |
| EP06765238A EP1855677B1 (en) | 2005-08-06 | 2006-08-04 | 3,11b cis dihydrotetrabanezine for the treatment of schizophrenia and other psychoses |
| PCT/GB2006/002936 WO2007017654A1 (en) | 2005-08-06 | 2006-08-04 | 3, hb cis dihydrotetrabanezine for the treatment of schizophrenia and other psychoses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1855677T3 true PL1855677T3 (pl) | 2009-07-31 |
Family
ID=37400949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06765238T PL1855677T3 (pl) | 2005-08-06 | 2006-08-04 | 3,11B-Cis-dihydrotetrabenazyny do leczenia schizofrenii i innych psychoz |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20110257220A1 (pl) |
| EP (2) | EP1855677B1 (pl) |
| JP (1) | JP2009504622A (pl) |
| KR (1) | KR20080033500A (pl) |
| AT (2) | ATE415968T1 (pl) |
| AU (1) | AU2006277753B2 (pl) |
| CA (1) | CA2620960A1 (pl) |
| CY (1) | CY1108843T1 (pl) |
| DE (1) | DE602006004009D1 (pl) |
| DK (1) | DK1855677T3 (pl) |
| ES (1) | ES2318771T3 (pl) |
| HR (1) | HRP20090074T3 (pl) |
| MX (1) | MX2008001549A (pl) |
| NZ (1) | NZ566011A (pl) |
| PL (1) | PL1855677T3 (pl) |
| PT (1) | PT1855677E (pl) |
| RS (1) | RS50807B (pl) |
| RU (1) | RU2407743C2 (pl) |
| SI (1) | SI1855677T1 (pl) |
| WO (1) | WO2007017654A1 (pl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007317242B2 (en) | 2006-11-08 | 2013-08-01 | Neurocrine Biosciences, Inc. | Substituted 3-isobutyl-9, 10-dimethoxy-1,3,4,6,7,11B-hexahydro-2H-pyrido[2,1-a] isoquinolin-2-ol compounds and methods relating thereto |
| US8008500B2 (en) | 2007-06-08 | 2011-08-30 | General Electric Company | Intermediates useful for making tetrabenazine compounds |
| US8053578B2 (en) | 2007-11-29 | 2011-11-08 | General Electric Company | Alpha-fluoroalkyl dihydrotetrabenazine imaging agents and probes |
| GB0810857D0 (en) * | 2008-06-13 | 2008-07-23 | Cambridge Lab Ireland Ltd | Pharmaceutical compounds |
| GB2463451A (en) | 2008-09-08 | 2010-03-17 | Cambridge Lab | 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia |
| GB2463283A (en) * | 2008-09-08 | 2010-03-10 | Cambridge Lab | 3,11b-cis-dihydrotetrabenazine for use in treating asthma |
| WO2011153157A2 (en) | 2010-06-01 | 2011-12-08 | Auspex Pharmaceutical, Inc. | Benzoquinolone inhibitors of vmat2 |
| US9658363B2 (en) | 2011-04-01 | 2017-05-23 | 3M Innovative Properties Company | Films including triazine-based ultraviolet absorbers |
| MX2016009817A (es) | 2014-01-27 | 2017-02-28 | Auspex Pharmaceuticals Inc | Inhibidores de benzoquinolina del transportador vesicular de monoaminas 2. |
| CN106061506A (zh) * | 2014-02-07 | 2016-10-26 | 纽罗克里生物科学有限公司 | 包含抗精神病药物和vmat2抑制剂的药物组合物及其用途 |
| LT3875459T (lt) | 2015-10-30 | 2024-02-26 | Neurocrine Biosciences, Inc. | Valbenazino dihidrochlorido druskos ir jų polimorfai |
| CA3009169A1 (en) | 2015-12-23 | 2017-06-29 | Neurocrine Biosciences, Inc. | Synthetic methods for preparation of (s)-(2r,3r,11br)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1h-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) |
| JP2020500875A (ja) * | 2016-12-02 | 2020-01-16 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | 統合失調症または統合失調感情障害を処置するためのバルベナジンの使用 |
| JP7090151B2 (ja) | 2017-01-27 | 2022-06-23 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | 特定のｖｍａｔ２インヒビターを投与するための方法 |
| GB201705303D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201705302D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201705304D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201705306D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| MA50175B1 (fr) | 2017-09-21 | 2025-05-30 | Neurocrine Biosciences, Inc. | Formulation de valbenazine à dosage élevé et compositions, procédés et kits associés |
| KR20250070134A (ko) | 2017-10-10 | 2025-05-20 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 특정 vmat2 억제제의 투여 방법 |
| AU2017435893B2 (en) | 2017-10-10 | 2023-06-29 | Neurocrine Biosciences, Inc | Methods for the administration of certain VMAT2 inhibitors |
| GB201808464D0 (en) | 2018-05-23 | 2018-07-11 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compounds for use in treating huntington's disease |
| SG11202100303QA (en) | 2018-08-15 | 2021-02-25 | Neurocrine Biosciences Inc | Methods for the administration of certain vmat2 inhibitors |
| US10940141B1 (en) | 2019-08-23 | 2021-03-09 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2843591A (en) * | 1958-07-15 | Method for preparing same | ||
| US2830993A (en) | 1958-04-15 | Quinolizine derivatives | ||
| CA2058640A1 (en) * | 1991-01-25 | 1992-07-26 | Richard R. Scherschlicht | Tricyclic pyridone derivative |
| US6087376A (en) * | 1997-02-05 | 2000-07-11 | University Of Kentucky Research Foundation | Use of lobeline compounds in the treatment of central nervous system diseases and pathologies |
| FR2770215B1 (fr) * | 1997-10-28 | 2000-01-14 | Pf Medicament | Derives d'aminomethyl-benzo[a]quinolizidine, leur preparation et leur application en therapeutique pour les maladies neurodegeneratives |
| GB2410947B (en) * | 2004-02-11 | 2008-09-17 | Cambridge Lab Ltd | Pharmaceutical compounds |
-
2006
- 2006-08-04 US US11/997,591 patent/US20110257220A1/en not_active Abandoned
- 2006-08-04 RU RU2008108623/04A patent/RU2407743C2/ru not_active IP Right Cessation
- 2006-08-04 CA CA002620960A patent/CA2620960A1/en not_active Abandoned
- 2006-08-04 ES ES06765238T patent/ES2318771T3/es active Active
- 2006-08-04 SI SI200630210T patent/SI1855677T1/sl unknown
- 2006-08-04 MX MX2008001549A patent/MX2008001549A/es active IP Right Grant
- 2006-08-04 PL PL06765238T patent/PL1855677T3/pl unknown
- 2006-08-04 WO PCT/GB2006/002936 patent/WO2007017654A1/en not_active Ceased
- 2006-08-04 AU AU2006277753A patent/AU2006277753B2/en not_active Expired - Fee Related
- 2006-08-04 NZ NZ566011A patent/NZ566011A/en not_active IP Right Cessation
- 2006-08-04 HR HR20090074T patent/HRP20090074T3/xx unknown
- 2006-08-04 AT AT06765238T patent/ATE415968T1/de active
- 2006-08-04 RS RSP-2009/0055A patent/RS50807B/sr unknown
- 2006-08-04 AT AT08170385T patent/ATE534391T1/de active
- 2006-08-04 EP EP06765238A patent/EP1855677B1/en active Active
- 2006-08-04 KR KR1020087005308A patent/KR20080033500A/ko not_active Withdrawn
- 2006-08-04 PT PT06765238T patent/PT1855677E/pt unknown
- 2006-08-04 DK DK06765238T patent/DK1855677T3/da active
- 2006-08-04 JP JP2008525620A patent/JP2009504622A/ja not_active Ceased
- 2006-08-04 DE DE602006004009T patent/DE602006004009D1/de active Active
- 2006-08-04 EP EP08170385A patent/EP2050451B1/en active Active
-
2009
- 2009-02-26 CY CY20091100221T patent/CY1108843T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1108843T1 (el) | 2014-07-02 |
| EP1855677B1 (en) | 2008-12-03 |
| SI1855677T1 (sl) | 2009-04-30 |
| PT1855677E (pt) | 2009-01-13 |
| CA2620960A1 (en) | 2007-02-15 |
| WO2007017654A1 (en) | 2007-02-15 |
| RS50807B (sr) | 2010-08-31 |
| NZ566011A (en) | 2011-01-28 |
| ATE415968T1 (de) | 2008-12-15 |
| EP2050451B1 (en) | 2011-11-23 |
| ATE534391T1 (de) | 2011-12-15 |
| MX2008001549A (es) | 2008-04-04 |
| RU2407743C2 (ru) | 2010-12-27 |
| EP2050451A1 (en) | 2009-04-22 |
| HRP20090074T3 (en) | 2009-04-30 |
| AU2006277753B2 (en) | 2011-11-10 |
| ES2318771T3 (es) | 2009-05-01 |
| EP1855677A1 (en) | 2007-11-21 |
| HK1111083A1 (en) | 2008-08-01 |
| US20110257220A1 (en) | 2011-10-20 |
| AU2006277753A1 (en) | 2007-02-15 |
| RU2008108623A (ru) | 2009-09-20 |
| KR20080033500A (ko) | 2008-04-16 |
| JP2009504622A (ja) | 2009-02-05 |
| DE602006004009D1 (de) | 2009-01-15 |
| DK1855677T3 (da) | 2009-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1855677E (pt) | 3-11b-cis-di-hidrotetrabenazina para o tratamento da esquizofrenia e de outras psicoses | |
| TW200612910A (en) | Medicaments comprising carbonyl compounds, and the use thereof | |
| TW200734311A (en) | New compounds | |
| PL1656346T3 (pl) | 1,2,3,4-Tetrapodstawiony indol do leczenia chorób dróg oddechowych | |
| IL173002A (en) | Use of calcitonin in the manufacture of oral medication for the prevention or treatment of osteoarthritis | |
| ZA200604114B (en) | Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease | |
| PL1799231T3 (pl) | Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli | |
| ZA200801170B (en) | 3,11B-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation | |
| IL186748A0 (en) | 4 - phenyl - 5 - oxo 1, 4, 5, 6, 7, 8 - hexahydroquinoline derivatives for the treatment of infertility | |
| IL186676A0 (en) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility | |
| AU2003258145A8 (en) | Substituted phenylindoles for the treatment of hiv | |
| MX2007000224A (es) | Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos. | |
| UA85471C2 (ru) | Применение оксикодона для лечения висцеральной боли | |
| IL186831A0 (en) | 4-phenyl- 5-oxo - 1,4,5,6,7,8 - hexahydroquinoline derivatives as medicaments for the treatment of infertility | |
| IL186672A0 (en) | Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections | |
| ZA200501288B (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma. | |
| PT2366393E (pt) | Roflumilaste para o tratamento da hipertensão pulmonar | |
| ZA200800999B (en) | Use of N-dibenz (b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy | |
| TW200714284A (en) | Novel method | |
| GB0513835D0 (en) | HIV inhibitors | |
| ZA200803101B (en) | 4-oxadiozolyl-piperidine compounds and use thereof | |
| HK1117520A (en) | Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections | |
| WO2007006548A3 (de) | Antibakterielle amid-makrozyklen vii | |
| AP2005003270A0 (en) | Composition for the treatment of humans. |